Cross-Talk between Toxins and Channels

A special issue of Toxins (ISSN 2072-6651).

Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 2938

Special Issue Editor


E-Mail Website
Guest Editor
Group of Nanobioengineering, Bioengineering Department, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences (IBCh RAS), 117997 Moscow, Russia
Interests: bioengineering; voltage-gated potassium (Kv) channels and peptide toxins; toxin-channel binding studies using fluorescent methods

Special Issue Information

Dear Colleagues,

Ion channels, being indispensable constituents of a biological membrane, are the focus of research in the fields of cell biology, physiology and molecular pharmacology. The conduction of ions across the membrane at very fast rates and a high degree of ion selectivity forms the basis of biological activity of a living cell, including electrical excitability, intracellular signaling pathways, and intercellular communication. The great variety of ion channels are mainly classified by the nature of the activating stimuli, which induce channel gating (e.g., voltage-gated, ligand-gated, and mechanosensitive channels), and by the types of ions passing through the gate (e.g., sodium, potassium, and calcium channels).

There is another world of molecules, organic toxins, which bind the channels, thus affecting their function. The most studied are peptide toxins from venomous animals (scorpions, spiders, snakes, etc.) and small organic ligands from poisonous plants, symbiotic bacteria, or dinoflagellates. The toxins structurally mirror the bioactive sites of the target channels, providing a remarkable example of the evolution of prey and predator at the molecular level. This molecular fine-tuning has resulted in a high affinity and specificity of toxin binding, which is especially true for peptide toxins having a multi-point channel-binding interface.

This Special Issue aims to bring together the latest research on animal and plant toxins to study the structure–functional relations of the channels, as well as their regulatory role in different physiological processes, which range from neuronal conductivity and muscle contraction to immune response, hormone secretion, proliferation, and apoptosis. This Special Issue will combine the efforts to further understand the involvement of ion channels in many hereditary and acquired diseases and demonstrate the potency of toxins as a novel class of therapeutic agents. Original research articles and reviews are welcome.

Dr. Oksana V. Nekrasova
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • ion channel
  • toxin
  • blocker
  • gating modifier
  • small-molecule ligand
  • binding
  • ion channel pharmacology

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

22 pages, 4596 KiB  
Article
Subtype-Selective Peptide and Protein Neurotoxic Inhibitors of Nicotinic Acetylcholine Receptors Enhance Proliferation of Patient-Derived Glioblastoma Cell Lines
by Elena Gondarenko, Diana Mazur, Marina Masliakova, Yana Ryabukha, Igor Kasheverov, Yuri Utkin, Victor Tsetlin, Mikhail Shahparonov, Denis Kudryavtsev and Nadine Antipova
Toxins 2024, 16(2), 80; https://doi.org/10.3390/toxins16020080 - 2 Feb 2024
Viewed by 1464
Abstract
Glioblastoma multiforme (GBM) is the most aggressive type of brain cancer, with a poor prognosis. GBM cells, which develop in the environment of neural tissue, often exploit neurotransmitters and their receptors to promote their own growth and invasion. Nicotinic acetylcholine receptors (nAChRs), which [...] Read more.
Glioblastoma multiforme (GBM) is the most aggressive type of brain cancer, with a poor prognosis. GBM cells, which develop in the environment of neural tissue, often exploit neurotransmitters and their receptors to promote their own growth and invasion. Nicotinic acetylcholine receptors (nAChRs), which play a crucial role in central nervous system signal transmission, are widely represented in the brain, and GBM cells express several subtypes of nAChRs that are suggested to transmit signals from neurons, promoting tumor invasion and growth. Analysis of published GBM transcriptomes revealed spatial heterogeneity in nAChR subtype expression, and functional nAChRs of α1*, α7, and α9 subtypes are demonstrated in our work on several patient-derived GBM microsphere cultures and on the U87MG GBM cell line using subtype-selective neurotoxins and fluorescent calcium mobilization assay. The U87MG cell line shows reactions to nicotinic agonists similar to those of GBM patient-derived culture. Selective α1*, α7, and α9 nAChR neurotoxins stimulated cell growth in the presence of nicotinic agonists. Several cultivating conditions with varying growth factor content have been proposed and tested. The use of selective neurotoxins confirmed that cell cultures obtained from patients are representative GBM models, but the use of media containing fetal bovine serum can lead to alterations in nAChR expression and functioning. Full article
(This article belongs to the Special Issue Cross-Talk between Toxins and Channels)
Show Figures

Figure 1

20 pages, 11391 KiB  
Article
Of Seven New K+ Channel Inhibitor Peptides of Centruroides bonito, α-KTx 2.24 Has a Picomolar Affinity for Kv1.2
by Kashmala Shakeel, Timoteo Olamendi-Portugal, Muhammad Umair Naseem, Baltazar Becerril, Fernando Z. Zamudio, Gustavo Delgado-Prudencio, Lourival Domingos Possani and Gyorgy Panyi
Toxins 2023, 15(8), 506; https://doi.org/10.3390/toxins15080506 - 15 Aug 2023
Cited by 1 | Viewed by 1111
Abstract
Seven new peptides denominated CboK1 to CboK7 were isolated from the venom of the Mexican scorpion Centruroides bonito and their primary structures were determined. The molecular weights ranged between 3760.4 Da and 4357.9 Da, containing 32 to 39 amino acid residues with three [...] Read more.
Seven new peptides denominated CboK1 to CboK7 were isolated from the venom of the Mexican scorpion Centruroides bonito and their primary structures were determined. The molecular weights ranged between 3760.4 Da and 4357.9 Da, containing 32 to 39 amino acid residues with three putative disulfide bridges. The comparison of amino acid sequences with known potassium scorpion toxins (KTx) and phylogenetic analysis revealed that CboK1 (α-KTx 10.5) and CboK2 (α-KTx 10.6) belong to the α-KTx 10.x subfamily, whereas CboK3 (α-KTx 2.22), CboK4 (α-KTx 2.23), CboK6 (α-KTx 2.21), and CboK7 (α-KTx 2.24) bear > 95% amino acid similarity with members of the α-KTx 2.x subfamily, and CboK5 is identical to Ce3 toxin (α-KTx 2.10). Electrophysiological assays demonstrated that except CboK1, all six other peptides blocked the Kv1.2 channel with Kd values in the picomolar range (24–763 pM) and inhibited the Kv1.3 channel with comparatively less potency (Kd values between 20–171 nM). CboK3 and CboK4 inhibited less than 10% and CboK7 inhibited about 42% of Kv1.1 currents at 100 nM concentration. Among all, CboK7 showed out-standing affinity for Kv1.2 (Kd = 24 pM), as well as high selectivity over Kv1.3 (850-fold) and Kv1.1 (~6000-fold). These characteristics of CboK7 may provide a framework for developing tools to treat Kv1.2-related channelopathies. Full article
(This article belongs to the Special Issue Cross-Talk between Toxins and Channels)
Show Figures

Graphical abstract

Back to TopTop